Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

TNF-α and IL-1β Modulate Blood-Brain Barrier Permeability and Decrease Amyloid-β Peptide Efflux in a Human Blood-Brain Barrier Model
Romain Versele, Emmanuel Sevin, Fabien Gosselet, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10235-10235
Open Access | Times Cited: 78

Showing 1-25 of 78 citing articles:

Mechanisms of Blood–Brain Barrier Protection by Microbiota-Derived Short-Chain Fatty Acids
Ekaterina Fock, Parnova Rg
Cells (2023) Vol. 12, Iss. 4, pp. 657-657
Open Access | Times Cited: 120
Brain edema formation and therapy after intracerebral hemorrhage
Yingfeng Wan, Katherine G. Holste, Ya Hua, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105948-105948
Open Access | Times Cited: 82
Role of tumor necrosis factor-alpha in the central nervous system: a focus on autoimmune disorders
Natalia Gonzalez Caldito
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 80
Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 9
The Crucial Role of the Blood–Brain Barrier in Neurodegenerative Diseases: Mechanisms of Disruption and Therapeutic Implications
Sehwan Kim, Un Ju Jung, Sang Ryong Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 2, pp. 386-386
Open Access | Times Cited: 5
Innate immune sensors and regulators at the blood brain barrier: focus on toll-like receptors and inflammasomes as mediators of neuro-immune crosstalk and inflammation
Çiğdem Acıoğlu, Stella Elkabes
Journal of Neuroinflammation (2025) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Hypometabolism, Alzheimer’s Disease, and Possible Therapeutic Targets: An Overview
Snehal Raut, Aditya Bhalerao, Michael R. Powers, et al.
Cells (2023) Vol. 12, Iss. 16, pp. 2019-2019
Open Access | Times Cited: 24
Chronic Stress-Induced Neuroinflammation: Relevance of Rodent Models to Human Disease
Abigail G. White, Elias Elias, Andrea Orozco, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 10, pp. 5085-5085
Open Access | Times Cited: 12
The Dual Role of Amyloid Beta-Peptide in Oxidative Stress and Inflammation: Unveiling Their Connections in Alzheimer’s Disease Etiopathology
Hugo Fanlo-Ucar, Pol Picón-Pagès, Víctor Herrera-Fernández, et al.
Antioxidants (2024) Vol. 13, Iss. 10, pp. 1208-1208
Open Access | Times Cited: 12
Intranasally administrated fusion-inhibitory lipopeptides block SARS-CoV-2 infection in mice and enable long-term protective immunity
Saïd Mougari, Valérie Favède, Camilla Predella, et al.
Communications Biology (2025) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Distinguishing Neuromyelitis Optica Spectrum Disorders Subtypes: A Study on AQP4 and C3d Epitope Expression in Cytokine‐Primed Human Astrocytes
Marlen Alisch, Franziska Foersterling, Dario Zocholl, et al.
Glia (2025)
Open Access | Times Cited: 1
Viruses and the Brain—A Relationship Prone to Trouble
Matylda Barbara Mielcarska, Barry T. Rouse
Viruses (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access | Times Cited: 1
Nanotechnology to Overcome Blood–Brain Barrier Permeability and Damage in Neurodegenerative Diseases
Adriana Jiménez, Enrique Estudillo, Mara A. Guzmán‐Ruiz, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 281-281
Open Access | Times Cited: 1
Lung infection by Pseudomonas aeruginosa induces neuroinflammation and blood–brain barrier dysfunction in mice
Nuria Villalba, Yonggang Ma, Sarah A. Gahan, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 23
Human BBB-on-a-chip reveals barrier disruption, endothelial inflammation, and T cell migration under neuroinflammatory conditions
Arya Lekshmi Nair, Linda Groenendijk, Roos Overdevest, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 21
Research progress on perioperative blood-brain barrier damage and its potential mechanism
Yong Qiu, Chunheng Mo, Shiyu Xu, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 19
Impact of Pesticide Residues on the Gut-Microbiota–Blood–Brain Barrier Axis: A Narrative Review
Maria Abou Diwan, Marwa Lahimer, Véronique Bach, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6147-6147
Open Access | Times Cited: 18
Glial growth factor 2 treatment alleviates ischemia and reperfusion-damaged integrity of the blood-brain barrier through decreasing Mfsd2a/caveolin-1-mediated transcellular and Pdlim5/YAP/TAZ-mediated paracellular permeability
Xiaoling Zhang, Weihong Du, Shuxia Qian, et al.
Acta Pharmacologica Sinica (2024) Vol. 45, Iss. 11, pp. 2241-2252
Closed Access | Times Cited: 5
25-Hydroxycholesterol attenuates tumor necrosis factor alpha-induced blood-brain barrier breakdown in vitro
Rodrigo Azevedo Loiola, Cindy Nguyen, Shiraz Dib, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 8, pp. 167479-167479
Open Access | Times Cited: 5
Is Drp1 a link between mitochondrial dysfunction and inflammation in Alzheimer’s disease?
Oualid Sbai, Veronica Bazzani, Shreya Tapaswi, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 12
Emerging concerns of blood-brain barrier dysfunction caused by neurotropic enteroviral infections
Shujie Han, Wangquan Ji, Guangcai Duan, et al.
Virology (2024) Vol. 591, pp. 109989-109989
Closed Access | Times Cited: 4
TNF-α Levels Are Increased in Patients with Subjective Cognitive Impairment and Are Negatively Correlated with β Amyloid-42
Sara Serafini, Gabriella Ferretti, Paola Monterosso, et al.
Antioxidants (2024) Vol. 13, Iss. 2, pp. 216-216
Open Access | Times Cited: 4
Unlocking the Potential of Low-Molecular-Weight (Poly)phenol Metabolites: Protectors at the Blood-Brain Barrier Frontier
Daniela Marques, Diogo Moura-Louro, Inês P. Silva, et al.
Neurochemistry International (2024) Vol. 179, pp. 105836-105836
Open Access | Times Cited: 4
Adipose tissue as a therapeutic target for vascular damage in Alzheimer's disease
Miriam Bettinetti‐Luque, Laura Trujillo‐Estrada, Eduardo García‐Fuentes, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 6, pp. 840-878
Open Access | Times Cited: 10
Polymerase delta-interacting protein 2 mediates brain vascular permeability by regulating ROS-mediated ZO-1 phosphorylation and localization at the interendothelial border
Keke Wang, Hongyan Qu, Ruinan Hu, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top